ZA200500838B - Combination of ZD6474, an inhibitor of the vascular endothelial growth factor receptor, with radiotherapy in the treatment of cancer - Google Patents

Combination of ZD6474, an inhibitor of the vascular endothelial growth factor receptor, with radiotherapy in the treatment of cancer

Info

Publication number
ZA200500838B
ZA200500838B ZA200500838A ZA200500838A ZA200500838B ZA 200500838 B ZA200500838 B ZA 200500838B ZA 200500838 A ZA200500838 A ZA 200500838A ZA 200500838 A ZA200500838 A ZA 200500838A ZA 200500838 B ZA200500838 B ZA 200500838B
Authority
ZA
South Africa
Prior art keywords
radiotherapy
cancer
inhibitor
treatment
combination
Prior art date
Application number
ZA200500838A
Inventor
Stephen R Wedge
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of ZA200500838B publication Critical patent/ZA200500838B/en

Links

ZA200500838A 2002-08-09 2005-01-27 Combination of ZD6474, an inhibitor of the vascular endothelial growth factor receptor, with radiotherapy in the treatment of cancer ZA200500838B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0218525A GB0218525D0 (en) 2002-08-09 2002-08-09 Combination therapy

Publications (1)

Publication Number Publication Date
ZA200500838B true ZA200500838B (en) 2006-08-30

Family

ID=9942012

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200500838A ZA200500838B (en) 2002-08-09 2005-01-27 Combination of ZD6474, an inhibitor of the vascular endothelial growth factor receptor, with radiotherapy in the treatment of cancer

Country Status (2)

Country Link
GB (1) GB0218525D0 (en)
ZA (1) ZA200500838B (en)

Also Published As

Publication number Publication date
GB0218525D0 (en) 2002-09-18

Similar Documents

Publication Publication Date Title
IL166522A0 (en) Combination of zd6474 an inhibitor of the vascularendothelial growth factor receptor with radiother apy in the treatment of cancer
WO2003075841A3 (en) Combination methods of inhibiting tumor growth with a vascular endothelial growth factor receptor antagonist
EP1501489A4 (en) Combination therapy for the treatment of cancer
BG108214A (en) Combination methods of inhibiting tumor growth with a vascular endothelial growth factor receptor antagonist
AU2003213144A1 (en) Alkylating agent combinations in the treatment of cancer
PL370029A1 (en) 2-amino-4-heteroarylaminopyrimidine derivatives for use in the treatment of cancer
EP1487492A4 (en) The prevention or treatment of cancer using integrin alphavbeta3 antagonists in combination with other agents
AU2003237367A8 (en) Use of nrg4, or inhibitors thereof, in the treatment of colon and pancreatic cancer
EP1482970A4 (en) Cancer therapy
IL180138A0 (en) 2,4,6-trisubstituted pyrimidines as phosphotidylinol (pi) 3-kinase inhibitors and their use in the treatment of cancer
EP1581244A4 (en) Novel therapeutic targets in cancer
IL178261A0 (en) Use of 5,10-methylene tetrahydrofolate for the treatment of cancer
EP1578782A4 (en) Combination therapy with co-stimulatory factors
EP1757296A4 (en) Method of controlling the proliferation of vascular endothelial cells and inhibiting lumen formation
EP1485109A4 (en) Vascular therapeutics
EP1543860A4 (en) Thread for vascular stent and vascular stent using the thread
AU2003212634A8 (en) Compounds useful in the treatment of cancer
EP1534299A4 (en) Methods for treating psychosis associated with interferon-alpha therapy
HK1105288A1 (en) Flavopereirine and alstonine combinations in the treatment and prevention of prostate cancer
ZA200210316B (en) Composition and its therapeutic use.
IL162818A0 (en) Combination therapy for the treatment of bacterialinfections
IL162941A0 (en) Carboxamidine derivatives and their use in the treatment of vascular diseases
HK1079116A1 (en) Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and radiotherapy
ZA200500838B (en) Combination of ZD6474, an inhibitor of the vascular endothelial growth factor receptor, with radiotherapy in the treatment of cancer
AU2003270487A1 (en) Use of statins in the prevention and treatment of radiation injury and other disorders associated with reduced endothelial thrombomodulin